Healthcare
Pfizer CEO Says COVID-19 Vaccine Could be Ready This Year
The Supreme Court Will Rule on Obamacare This Fall, but Congress May Have Already Saved It
AstraZeneca Halts COVID-19 Vaccine Study After Unexplained Illness
Aetna, BCBS, and Cigna Are Among the Top Health Insurance Companies
Sanofi Planning Pharma Ingredients IPO in Next Few Months
Abbott BinaxNOW COVID-19 Test Gets FDA Approval
Teva Pharmaceutical Faces Charges of Price Fixing Generic Drugs
Takeda Pharmaceutical Sells Japan Business to Blackstone for $2.3 Billion
U.S. Approves Coronavirus Treatment, FTSE 100 Jumps on Possible AstraZeneca Vaccine Approval
Kymera Therapeutics Sets IPO Price, Hits Nasdaq Today
Should You Buy Following the Dip in Moderna Stock?
Why Was Gilead-Galapagos Drug Filgotinib Rejected by the FDA?
AstraZeneca Secures Deal With Australia for COVID-19 Vaccine
Sanofi Is Buying Principia Biopharma for $3.7 Billion
FDA Approves SalivaDirect COVID-19 Test
Why Thermo Fisher Scientific Has Ended the Qiagen Deal
Thermo Fisher Scientific ended its deal to buy Qiagen on Thursday. Here's why the agreement has been nixed.
Inovio's Stock Price Swings Due to Coronavirus Vaccine Update
Teladoc's Stock Price Forecast Sinks After Livongo Deal
Biogen Will Pay Denali $1 Billion to Partner on Parkinson’s Drug